Mr. Assad Jalil

Mr. Jalil has extensive experience in all aspects of latest vitreoretinal surgery including 23G, 25G and 27G pars plana vitrectomies. He has a special interest in surgical and medical management of vitreous and retinal diseases including retinal detachment; diabetic retinopathy; macular diseases including macular hole and epiretinal membranes; floaters; retinal vein occlusions; and age-related macular degeneration (including the use of intravitreal anti-VEGF injections). His surgical expertise also encompasses simple and complex cataract surgery as well as dealing with complications of cataract surgery. In addition, he is an expert of complex, sight-threatening ocular inflammatory disorders (uveitis) especially in the use of immunosuppressive medications and vitrectomy in dealing with this condition. He regularly audits his practice to ensure the highest standards of quality of care.

In addition to his clinical expertise, Mr. Jalil is an integral part of the research team at Manchester Royal Eye Hospital which has pioneered research into, amongst others, retinal implants and retinal gene therapy. He is one of the few retinal surgeons in the world performing retinal gene therapy and recently carried out one of the first ocular gene therapy surgeries in UK on a patient with a rare inherited retinal disease.

Mr. Jalil has co-authored 3 book chapters in addition to more than 30 publications in peer-reviewed ophthalmic journals. He regularly presents at national and international meetings. He is the supervisor of the well renowned Clinical as well as the Research Vitreoretinal fellowships at Manchester Royal Eye Hospital, and is involved in training surgeons from all over the world.